We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Bacteria-Based Test Strips Can Monitor Blood Glucose

By LabMedica International staff writers
Posted on 26 Jan 2012
Segments of DNA embedded in bacteria can be coded to detect changes in osmolarity resulting from the presence of glucose in a blood sample.

Students at the Missouri University of Science and Technology (MST, Rolla, USA) used a nonvirulent strain of E.coli with designed genes integrated in the bacteria’s DNA, enabling them to sense the presence of glucose in correlation to changes in osmolarity. More...
When glucose is detected, the bacteria emit a yellow glow, and as its concentration rises, so does the light emitted glow brighter. The system might also eventually serve as the basis for a new method to monitor blood glucose levels by replacing the fluorescent gene with one that would make the bacteria change color, based on glucose concentrations.

To make the device, the students used an intermediate biobrick with a ribosome-binding site and the reporter gene (eYFP), which was then coupled to another biobrick that had three binding sites for the transcriptional regulatory protein phosphorylated OmpR. The phosphorlyation of OmpR by EnvZ (an inner membrane protein that senses osmolarity) positively correlated with the osmolarity of the system. When one or two of the binding sites are occupied, RNA polymerase is recruited to begin downstream transcription of eYFP. However, when all three OmpR binding sites are occupied, RNA polymerase cannot bind, the reporter gene can no longer be produced, and the system is inhibited.

As osmolarity increases from very low levels, the fluorescence produced by the system increases, until it reaches a threshold osmolarity level that when crossed causes the fluorescence to decrease as a result of the ensuing inherent down-regulation of the system. The activity of the system can be quantified because the two-component regulatory system of EnvZ and OmpR controls transcription of the eYFP gene, dictating the level of fluorescence.

“All you would have to do is put the DNA inside a bacteria and you've got your test strip,” said Erica Shannon, a senior year student in biological sciences at MST. “In the future, based on further research, an insulin gene could be added to this system for use in insulin pumps, where specific glucose levels trigger insulin production.”

The project was developed the system as part of an annual competition sponsored by the International Genetically Engineered Machine Foundation (iGEM; Boston, MA, USA) held during October 2011, in Indianapolis (IN, USA); the MST iGEM chapter received a silver medal for their effort.

Related Links:

Missouri University of Science and Technology
International Genetically Engineered Machine Foundation




Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Collection and Transport System
PurSafe Plus®
Gold Member
Hematology Analyzer
Medonic M32B
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.